AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the disease, based on more recent data than was included when the company announced the interim results of its U.S. clinical trial on Monday. nyti.ms
@forbes.com4 years ago
Russia’s Sputnik V Vaccine Is 92% Effective Against Symptomatic Covid-19, Early Results Show, But There Are No Plans To Bring It To The U.S.
@foxnews.com5 years ago
Fauci tells House committee vaccine progress strong, blames states reopening early for coronavirus surge
